小児心臓腫瘍診断の市場規模、シェア、動向分析レポート：腫瘍別、タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年

小児心臓腫瘍診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の小児心臓腫瘍診断の市場規模は2030年までに10億6,000万米ドルに達すると予測され、2024年から2030年までのCAGRは8.03％で成長すると予測されています。

同市場の成長は、医療技術に対する意識の高まりと進歩に起因しています。小児の先天性心疾患や腫瘍の増加に伴い、正確で早期診断ツールの需要が急増しています。高度な画像診断技術やバイオマーカーの改善などの技術革新により診断能力が向上し、小児心臓腫瘍の早期発見とより良い管理が可能になった。例えば、2021年6月、スペイン国立循環器研究センターとフィリップスは、研究目的のための超高速心臓MRIプロトコルの開発で提携しました。この提携は、腫瘍学研究の進展を含め、将来的に臨床を強化することを目的としています。このような技術革新は患者の予後を改善し、医療提供者がこれらの稀な疾患の診断と治療により効果的なソリューションを求めるようになり、市場の成長を促進します。

さらに、技術の進歩は小児心臓腫瘍診断薬市場に大きな影響を与え、その成長を牽引しています。高解像度のMRIやCTスキャン技術の開発により、小児の心臓腫瘍をより正確かつ詳細に画像化できるようになった。これらの画像診断法は早期発見と正確な診断を強化し、効果的な治療に不可欠です。さらに、診断プロセスへの人工知能（AI）の統合は、複雑な画像データを分析することにより、精度と効率をさらに向上させています。これらの技術が進化するにつれて、より優れた診断ツールを提供し、患者の転帰を改善し、小児心臓腫瘍治療に関連するヘルスケアコストを削減することにより、市場の成長が拡大すると予想されます。

小児医療への投資と腫瘍学研究への資金提供は、市場の成長を促進する極めて重要な要因です。小児ヘルスケアへの投資の増加は、小児の心臓腫瘍の正確な検出とモニタリングに不可欠な高解像度MRIやCTスキャンなどの高度な診断ツールや技術の開発を確実にします。例えば、2024年6月、Amazon Web Services Inc.は、小児医療の調査を進め、腫瘍を含む希少疾患の理解を深めるために1,000万米ドルを投資しました。こうした投資は技術的進歩を加速させるだけでなく、医療の質を向上させ、革新的な診断ソリューションの利用可能性を高めることで市場を拡大させる。

さらに、小児がん医療に対する一般の人々や専門家の理解が深まることで、先進的な診断ツールや早期発見法に対する需要が高まる。例えば、国際小児がんデーは、小児がんに対する認識を高め、罹患した小児、青少年、生存者、その家族への支援を示すことを目的とした世界の取り組みです。意識が高まるにつれて、特殊な画像技術や治療の市場も拡大し、この分野への投資や技術革新が進みます。このような小児医療への関心の高まりは、市場の拡大を支え、心臓腫瘍を患う小児の転帰を改善します。

小児心臓腫瘍診断市場レポート・ハイライト

• 原発性心腫瘍セグメントは、画像技術の進歩、認知度の向上、診断ツールの改善により、2023年には84.81%の最大シェアを占めました。これらの要因によって早期発見と治療が促進され、市場拡大が促進されます。
• 心エコー分野は、その非侵襲性、高度なイメージング能力、診断精度の向上により、2023年に60.76％の最大シェアを占めました。PhilipsやGEヘルスケアなどの主要企業は、先進技術でイノベーションを推進し、早期発見と治療成果を向上させています。
• 2023年には、病院・クリニック分野が73.89％と最大のシェアを占め、医療インフラの改善、資金調達、投資の増加がその要因となっています。強化された施設とリソースが高度な診断技術をサポートし、小児心臓腫瘍のより良い検出と管理につながっています。
• 北米地域は、小児心臓腫瘍診断の世界市場全体を支配し、2023年には36.44％の売上シェアを占めました。先進的な画像技術や研究を含む戦略的開拓とイノベーションが、この地域の市場成長を促進し、診断精度を高めています。
• 小児心臓腫瘍診断市場の競合シナリオは高く、主要企業が重要な地位を占めています。主要企業は、顧客のアンメットニーズに応えるため、新製品開発、買収、提携、合併、地域拡大など様々な戦略に取り組んでいます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 小児心臓腫瘍診断市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 小児心臓腫瘍診断市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 小児心臓腫瘍診断市場：腫瘍別推定・動向分析

• セグメントダッシュボード
• 小児心臓腫瘍診断市場：腫瘍変動分析
• 腫瘍別展望：小児心臓腫瘍診断市場
• 2018年から2030年までの市場規模と予測および動向分析
• 原発性心臓腫瘍
• 続発性心臓腫瘍

第5章 小児心臓腫瘍診断市場：タイプ別推定・動向分析

• セグメントダッシュボード
• 小児心臓腫瘍診断市場：タイプ変動分析
• 小児心臓腫瘍診断市場：タイプ別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 心エコー検査
• 磁気共鳴画像（MRI）
• コンピュータ断層撮影（CT）スキャン
• その他

第6章 小児心臓腫瘍診断市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 小児心臓腫瘍診断市場：最終用途変動分析
• 小児心臓腫瘍診断市場：最終用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 病院と診療所
• 政府保健省
• その他

第7章 小児心臓腫瘍診断市場：地域別推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • GE HealthCare
  • Siemens Healthineers AG
  • CANON MEDICAL SYSTEMS CORPORATION
  • Boston Scientific Corporation
  • Lantheus
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Medtronic

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 4. Global pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 5. Global pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 6. North America pediatric cardiac tumor diagnostic market, by region, 2018 - 2030 (USD Million)
• Table 7. North America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 8. North America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 9. North America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 10. U.S. pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 11. U.S. pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 12. U.S. pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 13. Canada pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 14. Canada pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 15. Canada pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 16. Mexico pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 17. Mexico pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 18. Mexico pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 19. Europe pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
• Table 20. Europe pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 21. Europe pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 22. Europe pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 23. UK pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 24. UK pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 25. UK pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 26. Germany pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 27. Germany pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 28. Germany pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
• Table 29. France pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 30. France pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 31. France pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
• Table 32. Italy pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 33. Italy pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 34. Italy pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 35. Spain pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 36. Spain pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 37. Spain pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 38. Denmark pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 39. Denmark pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 40. Denmark pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
• Table 41. Norway pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 42. Norway pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 43. Norway pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 44. Sweden pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 45. Sweden pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 46. Sweden pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 51. Japan pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 52. Japan pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 53. Japan pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 54. China pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 55. China pediatric cardiac tumor diagnostic market, by type 2018 - 2030 (USD Million)
• Table 56. China pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
• Table 57. India pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 58. India pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 59. India pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 60. Australia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 61. Australia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 62. Australia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 63. South Korea pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 64. South Korea pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 65. South Korea pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 66. Thailand pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 67. Thailand pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 68. Thailand pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 69. Latin America pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
• Table 70. Latin America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 71. Latin America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 72. Latin America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 73. Brazil pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 74. Brazil pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 75. Brazil pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 76. Argentina pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 77. Argentina pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 78. Argentina pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 79. Middle East & Africa pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 83. South Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 84. South Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 85. South Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 86. Saudi Arabia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 89. UAE pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 90. UAE pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 91. UAE pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
• Table 92. Kuwait pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
• Table 93. Kuwait pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
• Table 94. Kuwait pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Primary research pattern
• Fig. 3 Market research approaches
• Fig. 4 Value chain-based sizing & forecasting
• Fig. 5 Market formulation & validation
• Fig. 6 Pediatric cardiac tumor diagnostic market segmentation
• Fig. 7 Market driver analysis (current & future impact)
• Fig. 8 Market restraint analysis (current & future impact)
• Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 10 Porter's five forces analysis
• Fig. 11 Pediatric cardiac tumor diagnostic market, tumor outlook key takeaways (USD Million)
• Fig. 12 Pediatric cardiac tumor diagnostic market: tumor movement analysis (USD Million), 2023 & 2030
• Fig. 13 Primary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Secondary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Pediatric cardiac tumor diagnostic market, type outlook key takeaways (USD Million)
• Fig. 16 Pediatric cardiac tumor diagnostic market: type movement analysis (USD Million), 2023 & 2030
• Fig. 17 Echocardiography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Magnetic Resonance Imaging (MRI) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Computed Tomography (CT) scan market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Pediatric cardiac tumor diagnostic market, end use outlook key takeaways (USD Million)
• Fig. 22 Pediatric cardiac tumor diagnostic market: end use movement analysis (USD Million), 2023 & 2030
• Fig. 23 Hospitals and clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Government health department market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Pediatric cardiac tumor diagnostic market: regional key takeaways (USD Million)
• Fig. 27 Pediatric cardiac tumor diagnostic market: regional outlook, 2023 & 2030, USD Million
• Fig. 28 North America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 U.S. pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Canada pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Mexico pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Europe pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 UK pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Germany pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 France pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Spain pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Italy pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Norway pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Denmark pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Sweden pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Asia Pacific pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 China pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Japan pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 India pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 South Korea pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Australia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Thailand pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Latin America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Brazil pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Argentina pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Middle East and Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 South Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Saudi Arabia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 UAE pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Kuwait pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 List of key emerging company's/type disruptors/innovators

Pediatric Cardiac Tumor Diagnostic Market Growth & Trends:

The global pediatric cardiac tumor diagnostic market size is anticipated to reach USD 1.06 billion by 2030 and is projected to grow at a CAGR of 8.03% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing awareness and advancements in medical technology. With the rise in the prevalence of congenital heart conditions and tumors among children, the demand for accurate and early diagnostic tools has surged. Technological innovations, such as advanced imaging techniques and improved biomarkers, have enhanced diagnostic capabilities, allowing for earlier detection and better management of pediatric cardiac tumors. For instance, in June 2021, the Spanish National Center for Cardiovascular Research and Philips teamed up to develop an ultra-fast cardiac MRI protocol for research purposes. This collaboration aims to enhance clinical practice in the future, including advancements in oncology research. These innovations improve patient outcomes and drive market growth as healthcare providers seek more effective solutions for diagnosing and treating these rare conditions.

Moreover, technological advancements significantly impact the market for pediatric cardiac tumor diagnostics, driving its growth. The development of high-resolution MRI and CT scan technologies allows for more accurate and detailed imaging of cardiac tumors in children. These imaging modalities enhance early detection and precise diagnosis, which are crucial for effective treatment. In addition, the integration of artificial intelligence (AI) into diagnostic processes is further improving accuracy and efficiency by analyzing complex imaging data.As these technologies evolve, they are expected to expand market growth by providing better diagnostic tools, improving patient outcomes, and reducing healthcare costs associated with pediatric cardiac tumor care.

The investment in pediatric care and funding for oncology research are pivotal factors driving the growth of the market. Increased investment in pediatric healthcare ensures the development of advanced diagnostic tools and technologies, such as high-resolution MRI and CT scans, which are crucial for accurately detecting and monitoring cardiac tumors in children. For instance,in June 2024, Amazon Web Services Inc. invested USD 10 million to advance research in pediatric healthcare and enhance the understanding of rare diseases, including tumors. These investments not only accelerate technological advancements but also expand the market by improving the quality of care and increasing the availability of innovative diagnostic solutions.

Furthermore, increased public and professional understanding of pediatric oncology care drives demand for advanced diagnostic tools and early detection methods. For instance, International Childhood Cancer Day is a worldwide initiative aimed at raising awareness about childhood cancer and showing support for affected children, adolescents, survivors, and their families. As awareness grows, so does the market for specialized imaging technologies and treatments, leading to more investment and innovation in this field. This heightened focus on pediatric care supports market expansion and improves outcomes for children with cardiac tumors.

Pediatric Cardiac Tumor Diagnostic Market Report Highlights:

• The primary cardiac tumors segment held the largest share, 84.81%, in 2023due to advancements in imaging technologies, increased awareness, and improved diagnostic tools. These factors enhance early detection and treatment, driving market expansion.
• The echocardiography segment held the largest share, 60.76%, in 2023 due to its noninvasive nature, advanced imaging capabilities, and enhanced diagnostic accuracy. Key players like Philips and GE Healthcare drive innovation with advanced technology, improving early detection and treatment outcomes.
• The hospitals and clinics segment held the largest share, 73.89%, in 2023, fueledby improved healthcare infrastructure, increased funding, and investment. Enhanced facilities and resources support advanced diagnostic technologies, leading to better detection and management of pediatric cardiac tumors.
• The North America region dominated the overall global market for pediatric cardiac tumor diagnosticsand accounted for the 36.44% revenue share in 2023. Strategic development and innovation, including advanced imaging technologies and research, drive market growth and enhance diagnostic accuracy in this region.
• The competitive scenario in the pediatric cardiac tumor diagnostic market is high, with key players holding significant positions. The major companies are undertaking various strategies, such as new product development, acquisitions, collaborations, mergers, and regional expansion, to serve their customers' unmet needs.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Tumor
  • 1.2.2. Type
  • 1.2.3. End use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Tumor outlook
  • 2.2.2. Type outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pediatric Cardiac Tumor Diagnostic Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Pediatric Cardiac Tumor Diagnostic Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pediatric Cardiac Tumor Diagnostic Market: Tumor Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pediatric Cardiac Tumor Diagnostic Market: Tumor Movement Analysis
• 4.3. Pediatric Cardiac Tumor Diagnostic Market by Tumor Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Primary Cardiac Tumors
  • 4.5.1. Primary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Secondary Cardiac Tumors
    • 4.5.2.1. Secondary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pediatric Cardiac Tumor Diagnostic Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pediatric Cardiac Tumor Diagnostic Market: Type Movement Analysis
• 5.3. Pediatric Cardiac Tumor Diagnostic Market by Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Echocardiography
  • 5.5.1. Echocardiography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Magnetic Resonance Imaging (MRI)
  • 5.6.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Computed Tomography (CT) Scan
  • 5.7.1. Computed Tomography (CT) Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pediatric Cardiac Tumor Diagnostic Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pediatric Cardiac Tumor Diagnostic Market: End Use Movement Analysis
• 6.3. Pediatric Cardiac Tumor Diagnostic Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals and Clinics
  • 6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Government Health Department
  • 6.6.1. Government Health Department Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pediatric Cardiac Tumor Diagnostic Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. GE HealthCare
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Siemens Healthineers AG
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. CANON MEDICAL SYSTEMS CORPORATION
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Boston Scientific Corporation
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Lantheus
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Bio-Rad Laboratories, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Abbott
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. F. Hoffmann-La Roche Ltd
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Medtronic
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives